Otavio Berwanger

16PUBLICATIONS
169CO-AUTHORS
Neurology and neuromuscular diseasesPredictive and prognostic markersInfectious diseasesPharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 06, 2024
Laboratory profiles of patients hospitalized with COVID-19 pneumonia treated with tofacitinib or placebo: a post hoc analysis from the STOP-COVID trial.

Patrícia Oliveira Guimarães, Lucas Petri Damiani, Caio de Assis Moura Tavares

|Aug 14, 2024
Mortality, hospitalizations, and persistence of symptoms in the outpatient setting of the first COVID-19 wave in Brazil: results of SARS-Brazil cohort study.

Henrique Andrade Rodrigues Fonseca, Adriano Jose Pereira, Ricardo Kenji Nawa

|Jul 01, 2024
Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial.

Pedro Gabriel Melo de Barros E Silva, Ariane Vieira Scarlatelli Macedo, Bruna Bronhara

|Dec 22, 2023
Dapagliflozin in patients with critical illness: rationale and design of the DEFENDER study.

Caio de Assis Moura Tavares, Luciano César Pontes de Azevedo, Álvaro Rea-Neto

Pageof 3